- £32.97bn
- £40.46bn
- £11.03bn
Sensodyne maker Haleon posts higher second-quarter organic revenue growth
2026 Half Year Results
UK Stocks-Factors to watch on July 30
Director/PDMR Shareholding
UK Stocks-Factors to watch on June 29 (updated)
UK Stocks-Factors to watch on June 29
Deals of the day-Mergers and acquisitions
Haleon among bidders for supplements maker Thorne, sources say (updated)
Europe Research Roundup: Banca Generali, Ferrari, Prysmian
Brief: Haleon Issues Voluntary Recall Of Gas-X Extra Strength Softgels 125 MG, 120 CT & 72 CT
Director/PDMR Shareholding
Director/PDMR Shareholding
Europe Research Roundup: Burberry, Hochtief, Volex
UK's Haleon falls after quarterly revenue miss
UK Stocks-Factors to watch on April 29 (updated)
Brief: Haleon Says Q1 North America Organic Revenue Growth Was Up 1.0%
Sensodyne maker Haleon reports organic revenue growth slightly below estimates (updated)
Sensodyne maker Haleon reports organic revenue growth sligtly below estimates
Haleon 2026 Q1 Trading Statement